In vivo PET imaging of beta-amyloid deposition in mouse models of Alzheimer's disease with a high specific activity PET imaging agent [(18)F]flutemetamol.

MLA

Snellman, Anniina, et al. “In Vivo PET Imaging of Beta-Amyloid Deposition in Mouse Models of Alzheimer’s Disease with a High Specific Activity PET Imaging Agent [(18)F]Flutemetamol.” EJNMMI Research, vol. 4, Aug. 2014, p. 37. EBSCOhost, https://doi.org/10.1186/s13550-014-0037-3.

APA

Snellman, A., Rokka, J., López-Picón, F. R., Eskola, O., Salmona, M., Forloni, G., Scheinin, M., Solin, O., Rinne, J. O., & Haaparanta-Solin, M. (2014). In vivo PET imaging of beta-amyloid deposition in mouse models of Alzheimer’s disease with a high specific activity PET imaging agent [(18)F]flutemetamol. EJNMMI Research, 4, 37. https://doi.org/10.1186/s13550-014-0037-3

Chicago

Snellman, Anniina, Johanna Rokka, Francisco R López-Picón, Olli Eskola, Mario Salmona, Gianluigi Forloni, Mika Scheinin, Olof Solin, Juha O Rinne, and Merja Haaparanta-Solin. 2014. “In Vivo PET Imaging of Beta-Amyloid Deposition in Mouse Models of Alzheimer’s Disease with a High Specific Activity PET Imaging Agent [(18)F]Flutemetamol.” EJNMMI Research 4 (August): 37. doi:10.1186/s13550-014-0037-3.